Heterozygous mutations in CTLA4 leading to haploinsufficiency and impaired CTLA4 dimerization or impaired ligand binding, result in an autosomal dominant immune dysregulation syndrome with immunodeficiency. This evidence concerns the gene CTLA4 and immune system disorder.